Latest Breaking News On - Treatment guidelines - Page 5 : comparemela.com

ACCORD (ACcurate COnsensus Reporting Document): A reporting guideline for consensus methods in biomedicine developed via a modified Delphi

Gattrell and colleagues developed the ACCORD reporting guideline to guide the reporting of biomedical studies using consensus methods.

United kingdomUnited statesCity ofMarlen niederbergerLinda romagnanoAlexandra frances kavaneyKonstantinp vorobyovRobert matheisWilliamr phillipsWeini qiuCareym suehsBob stevensCurtis sonnyLidwineb mokkinkBrians alperBernd arents

First ALL Treatment Guidance for Young Patients in the Works

: The American Society of Hematology is developing the first clinical practice guidelines for treating acute lymphocytic leukemia in adolescents and young adults.

United statesKristen odwyerSumit guptaUniversity of chicagoUniversity of rochesterNational cancer instituteAmerican society of hematologyAmerican societyWendy stockSick childrenKristeno dwyerAcute leukemiaAcute leukaemiaClinical guidelinesTreatment guidelinesAdolescent medicine

FDA Expands Label for CVRx Barostim System in HF

The Barostim neuromodulation system is now indicated in NYHA class III or class II HF despite guideline-directed medical therapies, with LVEF ≤ 35% and NT-proBNP < 1600 pg/mL.

Nadim yaredDrug administrationCvrx incYork heart associationNew york heart associationHeart failureCardiovascular imagingArdiac imagingV imagingRejection fractionF ejection fractionLeft ventricular ejection fractionClinical guidelinesTreatment guidelinesHealthcare and medical technologyEalth and medical tech

Reviews uncover no consistent link between antiviral drugs like Paxlovid and COVID rebound

Reviews uncover no consistent link between antiviral drugs like Paxlovid and COVID rebound
umn.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from umn.edu Daily Mail and Mail on Sunday newspapers.

National institutes of healthCenters for diseaseDrug administrationMortality weeklyNational institutesTreatment guidelinesDisease control

Use of suboptimal control arms in randomized clinical trials of investigational cancer drugs in China, 2016–2021: An observational study

In this observational study, Yichen Zhang and colleagues explore how comparator arms are used in randomized oncology trials registered in China.

Eteläuomen läiUnited statesAnitak wagnerHuseyin naciNational medical products administrationChinese society of clinical oncologyDrug administrationUniversity health science centerHarvard medical schoolLondon school of economicsOriented oncology drug researchNational natural science foundation of chinaOncologic drugs advisory committeeChina centerNational comprehensive cancer networkChina national knowledge infrastructure